In 2026, organizations pivot to sustainable, custom-printed balloons to drive high-impact branding, social media reach, ...

Boston, Massachusetts - February 25, 2026 - PRESSADVANTAGE - Enterprise resource planning systems were once judged ...

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

New delivery model applies AI across engineering, testing, DevOps, and analytics to improve speed, transparency, and ...

The Paper House expands into hybrid publishing, offering authors more flexible and professional publishing options.

Neolith’s booth was a standout destination to explore the brand’s newest textures and product innovations, showcased ...

A landmark global study co‑led by Dalhousie researchers offers the clearest picture yet of anxiety’s biological roots, ...

New Practice Group Targets Businesses That Benefit From Trafficking, Including Hotels and Motels These cases reflect a ...

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

Coinciding with Global Change Management Day, the Association Reflects on Growth, Impact, and Global Credibility Over ...

Expansion underscores Beond’s evolution from crisis recovery to proactive mental wellness, optimization and whole-person care ...

"Results support the further development of TSND-201 as a potential acute, intermittent treatment for PTSD," they concluded. "Together, these results demonstrate that TSND-201 has the potential to be ...